Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.435 USD | +6.35% | -20.73% | +197.44% |
Jun. 04 | Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer | CI |
May. 21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 35.39M | Capitalization | 70.53M |
---|---|---|---|---|---|
Net income 2024 * | -38M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
-1.68
x | P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.14% |
1 day | -14.10% | ||
1 week | -25.92% | ||
Current month | -32.00% | ||
1 month | -1.52% | ||
3 months | +118.24% | ||
6 months | +251.13% | ||
Current year | +176.07% |
Managers | Title | Age | Since |
---|---|---|---|
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 18-08-02 |
Director of Finance/CFO | 49 | 23-08-31 | |
Sergei Gryaznov
CTO | Chief Tech/Sci/R&D Officer | 64 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 20-03-31 | |
Ramiro Guerrero
BRD | Director/Board Member | 59 | - |
Steven Chaouki
BRD | Director/Board Member | 51 | 21-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 3.48 | +7.74% | 451 343 |
24-06-05 | 3.23 | -14.10% | 695,200 |
24-06-04 | 3.76 | -26.27% | 1,505,041 |
24-06-03 | 5.1 | +7.37% | 967,599 |
24-05-31 | 4.75 | +8.20% | 418,032 |
Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+176.07% | 70.53M | |
+55.70% | 59.34B | |
+43.12% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- MAIA Stock